The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of trifluridine/tipiracil (FTD/TPI) in HER2-negative metastatic breast cancers with or without prior exposure to fluoropyrimidines.
 
Joline Si Jing Lim
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; DKSH; Everest Medicine; MSD; Novartis; Pfizer
Research Funding - CTI BioPharma Corp (Inst)
Travel, Accommodations, Expenses - MSD
 
Samuel Guan Wei Ow
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer
 
Andrea Wong
Consulting or Advisory Role - AstraZeneca; DKSH; Eisai; Pfizer
Research Funding - Otsuka Pharmaceuticals
 
Matilda Lee
No Relationships to Disclose
 
Gloria HJ Chan
Honoraria - Roche
Travel, Accommodations, Expenses - AstraZeneca
 
Jia Li Low
No Relationships to Disclose
 
Raghav Sundar
Stock and Other Ownership Interests - Teladoc
Honoraria - AstraZeneca; Bristol-Myers Squibb; DKSH; Ipsen; Lilly; MSD; Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; DKSH; Eisai; GlaxoSmithKline; Merck; MSD; Novartis; Taiho Pharmaceutical
Research Funding - MSD; Natera; Paxman
Travel, Accommodations, Expenses - AstraZeneca; DKSH; Eisai; Roche; Taiho Pharmaceutical
 
Joan RE Choo
Travel, Accommodations, Expenses - AstraZeneca
 
Bee Choo Tai
No Relationships to Disclose
 
Soo-Chin Lee
Consulting or Advisory Role - ACT Genomics; AstraZeneca; Eisai; Lilly O.; Novartis; Pfizer; Roche
Research Funding - ACT Genomics; Eisai; Pfizer; Taiho Pharmaceutical